The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2019
Filed:
Apr. 24, 2018
Applicant:
Gesea Biosciences Inc., Lynnwood, WA (US);
Inventors:
John H. Baillie, Glen Ellen, CA (US);
Ruth Baillie, Glen Ellen, WA (US);
George Blouin, Lynnwood, WA (US);
Newsha Farahani, Issaquah, WA (US);
Christopher Marx, Mukilteo, WA (US);
Assignee:
GESEA BIOSCIENCES, INC., San Luis Obispo, CA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61F 6/08 (2006.01); A61F 6/22 (2006.01); A61K 31/167 (2006.01); A61K 31/192 (2006.01); A61K 31/325 (2006.01); A61K 31/57 (2006.01); A61K 31/593 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61K 31/567 (2006.01); A61K 47/36 (2006.01); A61K 9/50 (2006.01); A61F 2/30 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0024 (2013.01); A61F 6/08 (2013.01); A61F 6/22 (2013.01); A61K 9/0002 (2013.01); A61K 9/5021 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/325 (2013.01); A61K 31/567 (2013.01); A61K 31/57 (2013.01); A61K 31/593 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); A61K 47/36 (2013.01); A61F 2002/30677 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); A61L 2300/404 (2013.01);
Abstract
A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.